LIGAND PHARMACEUTICALS INCORPORATED Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One of $296.09 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue · last filed 2026-02-27
- 2025-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $296.09M.
- 2024-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $127.33M.
- 2023-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $55.38M.
- 2022-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $57.04M.
| Period end | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One |
|---|---|
| 2025-12-31 | $296.09M 10-K · filed 2026-02-27 |
| 2024-12-31 | $127.33M 10-K · filed 2025-02-28 |
| 2023-12-31 | $55.38M 10-K · filed 2024-02-29 |
| 2022-12-31 | $57.04M 10-K · filed 2023-02-28 |
| 2021-12-31 | $111.31M 10-K · filed 2022-02-28 |
| 2020-12-31 | $141.79M 10-K · filed 2021-02-24 |